Singapore, Singapore
Clinician Scientist & Healthcare executive driving national-level clinical artificial intelligence (AI) & digital health initiatives in Singapore. Has over a decade of experience leading medical affairs and digital transformation in APAC healthcare markets across corporate healthcare services, government/public sector, private equity, and VC-backed environments, in parallel with his practice in Primary Care. Current work includes clinical evaluation of digital health, governance frameworks for generative and agentic AI systems, red-team testing methodologies, and digital transformation of healthcare services. He has successfully scaled clinical GTM strategy for population-level, digitally-enabled healthcare services across Primary care, Mental Health, Ophthalmology, Public health, and other verticals, accumulating deep experience in medical affairs, government affairs, and regulatory affairs. Works directly with software engineering (SWE) teams in matrix environments as lead clinical subject matter expert, partnering ML/AI engineering, UX, policy, legal, and regulatory teams to develop, validate, and deploy clinically safe, high-performing digital health and clinical AI solutions. Completed a PhD in clinical AI implementation and has >50 publications (i10-index 43, h-index 29) on management of digital health information technology systems in medical journals such as JAMA Ophthalmology, Nature Digital medicine, Lancet Digital health, and NEJM AI. He is a twice exited co-founder of 2 digital health start-ups including an online health community AskDr having closed paid contracts with Fortune 500 companies as well as Doctorbell, an enterprise SaaS patient engagement platform (acquired by Mobile-Health Network Solutions, NASDAQ:$MNDR). Particularly interested in questions relating to human computer interaction, scalable oversight, evaluation of agentic clinical AI systems, digital health risk mitigation, and safe integration of AI into complex socio-technical workflows. He has received accolades for contributions to the health technology ecosystem in Asia including being named on the 2018 Forbes 30 under 30 list (Science and Health), awarded the 2019 Commonwealth Fellowship in Innovation from the British High Commission of Singapore (for training at Oxford University and Moorfields Eye Hospital London) & the 2024 Young Southeast Asian Leaders (YSEALI) award from the United States (US) Embassy.
Clinical and Applied Artificial Intelligence (AI) subject matter expert for product development teams of national level AI-enabled digital health tools, driving medical affairs for digital health adoption, market access strategy, as well as software as a medical device (SaMD) regulatory strategy for clinical AI solutions in a corporate venture builder (Data, Science and Technology team) serving unmet clinical needs.
Appointed to teach about the latest developments in Digital Health, Artificial Intelligence (AI), and Medical Innovation to undergraduates from faculties of Medicine/Health disciplines, Computing, Engineering disciplines, Business, and others.
Appointed to advise on incorporation of innovation in undergraduate curriculum, lecture on sustainable medial innovation and health technology.
Honorary appointment under the Ophthalmology & Visual Sciences Academic Clinical Program (ACP).
Driving digital strategy across group assets in Northeast Health International (NHI) post-acquisition by parent company Sheares Healthcare (Private Equity backed by Temasek), with twin goals of clinical quality improvement and operational value creation. Directly managed digital transformation initiatives from implementation of telehealth to several artificial intelligence (AI)-enabled clinical services in primary care, targeting margin expansion and omni-channel clinical workflow optimisation. Led his team to capture strategic opportunities that convert the cost center for digital health application development into a potential revenue leader by securing grant funding for software development as well as pre-sales through commercial deals with academic institutions and pharmaceuticals.
Led operationalisation of telehealth with direct-to-consumer video consultation as well as hybrid virtual clinics. Led both clinical and commercial initiatives, with the former including the development of clinical protocols for virtual care and medical affairs with continuing medical education (CME) campaigns and training sessions with private general practitioners (GPs), family physicians, surgeons, and specialists for best practices in telehealth and remote care for patients. Also led commercial initiatives including partnership evaluation, market penetration through joint initiatives with other digital health stakeholders, project management and clinical advisory to software development team.